Brokerages expect Exponent, Inc. (NASDAQ:EXPO) to post earnings per share of $0.41 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Exponent’s earnings. Exponent reported earnings of $0.39 per share during the same quarter last year, which indicates a positive year over year growth rate of 5.1%. The company is scheduled to issue its next earnings results on Wednesday, February 7th.

On average, analysts expect that Exponent will report full year earnings of $2.09 per share for the current financial year, with EPS estimates ranging from $2.08 to $2.10. For the next year, analysts forecast that the business will post earnings of $2.09 per share, with EPS estimates ranging from $1.95 to $2.26. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for Exponent.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Wednesday, October 18th. The business services provider reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.09. Exponent had a net margin of 16.46% and a return on equity of 17.21%. The company had revenue of $87.60 million during the quarter, compared to the consensus estimate of $79.69 million. During the same period in the previous year, the firm posted $0.42 EPS. The firm’s revenue was up 12.9% compared to the same quarter last year.

A number of equities analysts have issued reports on EXPO shares. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Friday, October 20th. Cantor Fitzgerald restated a “buy” rating and issued a $75.00 price objective (up previously from $69.00) on shares of Exponent in a research report on Wednesday, July 19th. ValuEngine upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Thursday, July 20th. Finally, SunTrust Banks, Inc. reiterated a “hold” rating and set a $77.00 price target on shares of Exponent in a research report on Thursday, October 19th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $80.00.

COPYRIGHT VIOLATION NOTICE: “Exponent, Inc. (EXPO) Expected to Announce Earnings of $0.41 Per Share” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/11/04/exponent-inc-expo-expected-to-announce-earnings-of-0-41-per-share.html.

In other Exponent news, CEO Paul R. Johnston sold 4,095 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $65.84, for a total transaction of $269,614.80. Following the completion of the sale, the chief executive officer now directly owns 57,240 shares of the company’s stock, valued at $3,768,681.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Paul R. Johnston sold 5,000 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $64.41, for a total transaction of $322,050.00. Following the completion of the sale, the chief executive officer now directly owns 66,335 shares of the company’s stock, valued at $4,272,637.35. The disclosure for this sale can be found here. In the last quarter, insiders sold 54,851 shares of company stock worth $3,710,760. Insiders own 2.80% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new position in Exponent during the second quarter valued at $278,000. Gotham Asset Management LLC bought a new position in Exponent during the first quarter valued at $394,000. UBS Asset Management Americas Inc. lifted its holdings in shares of Exponent by 6.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 60,030 shares of the business services provider’s stock worth $3,500,000 after acquiring an additional 3,857 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Exponent by 2.3% in the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock worth $12,249,000 after acquiring an additional 4,794 shares during the last quarter. Finally, Citadel Advisors LLC lifted its holdings in shares of Exponent by 70.1% in the 2nd quarter. Citadel Advisors LLC now owns 10,604 shares of the business services provider’s stock worth $618,000 after acquiring an additional 4,370 shares during the last quarter. 88.67% of the stock is owned by institutional investors.

Exponent (NASDAQ EXPO) traded up $0.95 during midday trading on Friday, hitting $73.55. 62,114 shares of the stock were exchanged, compared to its average volume of 105,652. The company has a market cap of $1,897.08, a P/E ratio of 40.19 and a beta of 0.58. Exponent has a 52 week low of $55.75 and a 52 week high of $77.15.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Friday, December 1st will be issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Thursday, November 30th. Exponent’s dividend payout ratio (DPR) is presently 40.98%.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.